208 related articles for article (PubMed ID: 35204766)
1. Channelopathy Genes in Pulmonary Arterial Hypertension.
Welch CL; Chung WK
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204766
[TBL] [Abstract][Full Text] [Related]
2. Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension.
Redel-Traub G; Sampson KJ; Kass RS; Bohnen MS
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291551
[TBL] [Abstract][Full Text] [Related]
3. Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.
Welch CL; Aldred MA; Balachandar S; Dooijes D; Eichstaedt CA; Gräf S; Houweling AC; Machado RD; Pandya D; Prapa M; Shaukat M; Southgate L; Tenorio-Castano J; ; Chung WK;
Genet Med; 2023 Nov; 25(11):100925. PubMed ID: 37422716
[TBL] [Abstract][Full Text] [Related]
4. KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models.
West JD; Austin ED; Rizzi EM; Yan L; Tanjore H; Crabtree AL; Moore CS; Muthian G; Carrier EJ; Jacobson DA; Hamid R; Kendall PL; Majka S; Rathinasabapathy A
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065088
[TBL] [Abstract][Full Text] [Related]
5. KCNK3: new gene target for pulmonary hypertension?
Girerd B; Perros F; Antigny F; Humbert M; Montani D
Expert Rev Respir Med; 2014 Aug; 8(4):385-7. PubMed ID: 24742047
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Heterozygous
Bohnen MS; Roman-Campos D; Terrenoire C; Jnani J; Sampson KJ; Chung WK; Kass RS
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28889099
[TBL] [Abstract][Full Text] [Related]
7. The genetic basis of pulmonary arterial hypertension.
Ma L; Chung WK
Hum Genet; 2014 May; 133(5):471-9. PubMed ID: 24442418
[TBL] [Abstract][Full Text] [Related]
8. A novel channelopathy in pulmonary arterial hypertension.
Ma L; Roman-Campos D; Austin ED; Eyries M; Sampson KS; Soubrier F; Germain M; Trégouët DA; Borczuk A; Rosenzweig EB; Girerd B; Montani D; Humbert M; Loyd JE; Kass RS; Chung WK
N Engl J Med; 2013 Jul; 369(4):351-361. PubMed ID: 23883380
[TBL] [Abstract][Full Text] [Related]
9. Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension.
Le Ribeuz H; Capuano V; Girerd B; Humbert M; Montani D; Antigny F
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32882918
[TBL] [Abstract][Full Text] [Related]
10. Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension.
Eichstaedt CA; Saßmannshausen Z; Shaukat M; Cao D; Xanthouli P; Gall H; Sommer N; Ghofrani HA; Seyfarth HJ; Lerche M; Halank M; Kleymann J; Benjamin N; Harutyunova S; Egenlauf B; Milger K; Rosenkranz S; Ewert R; Klose H; Hoeper MM; Olsson KM; Lankeit M; Lange TJ; Hinderhofer K; Grünig E
Respir Res; 2022 Mar; 23(1):74. PubMed ID: 35346192
[TBL] [Abstract][Full Text] [Related]
11. Whole Exome Sequence Analysis Provides Novel Insights into the Genetic Framework of Childhood-Onset Pulmonary Arterial Hypertension.
Gelinas SM; Benson CE; Khan MA; Berger RMF; Trembath RC; Machado RD; Southgate L
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33187088
[TBL] [Abstract][Full Text] [Related]
12. An homozygous mutation in KCNK3 is associated with an aggressive form of hereditary pulmonary arterial hypertension.
Navas Tejedor P; Tenorio Castaño J; Palomino Doza J; Arias Lajara P; Gordo Trujillo G; López Meseguer M; Román Broto A; Lapunzina Abadía P; Escribano Subía P
Clin Genet; 2017 Mar; 91(3):453-457. PubMed ID: 27649371
[TBL] [Abstract][Full Text] [Related]
13. The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension.
Haarman MG; Kerstjens-Frederikse WS; Vissia-Kazemier TR; Breeman KTN; Timens W; Vos YJ; Roofthooft MTR; Hillege HL; Berger RMF
J Pediatr; 2020 Oct; 225():65-73.e5. PubMed ID: 32502478
[TBL] [Abstract][Full Text] [Related]
14. Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension.
Cunningham KP; Holden RG; Escribano-Subias PM; Cogolludo A; Veale EL; Mathie A
J Physiol; 2019 Feb; 597(4):1087-1101. PubMed ID: 30365877
[TBL] [Abstract][Full Text] [Related]
15. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
16. Biallelic variants of
Machado RD; Welch CL; Haimel M; Bleda M; Colglazier E; Coulson JD; Debeljak M; Ekstein J; Fineman JR; Golden WC; Griffin EL; Hadinnapola C; Harris MA; Hirsch Y; Hoover-Fong JE; Nogee L; Romer LH; Vesel S; ; Gräf S; Morrell NW; Southgate L; Chung WK
J Med Genet; 2022 Sep; 59(9):906-911. PubMed ID: 34493544
[TBL] [Abstract][Full Text] [Related]
17. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
[TBL] [Abstract][Full Text] [Related]
18. Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.
Bohnen MS; Ma L; Zhu N; Qi H; McClenaghan C; Gonzaga-Jauregui C; Dewey FE; Overton JD; Reid JG; Shuldiner AR; Baras A; Sampson KJ; Bleda M; Hadinnapola C; Haimel M; Bogaard HJ; Church C; Coghlan G; Corris PA; Eyries M; Gibbs JSR; Girerd B; Houweling AC; Humbert M; Guignabert C; Kiely DG; Lawrie A; MacKenzie Ross RV; Martin JM; Montani D; Peacock AJ; Pepke-Zaba J; Soubrier F; Suntharalingam J; Toshner M; Treacy CM; Trembath RC; Vonk Noordegraaf A; Wharton J; Wilkins MR; Wort SJ; Yates K; Gräf S; Morrell NW; Krishnan U; Rosenzweig EB; Shen Y; Nichols CG; Kass RS; Chung WK
Circ Genom Precis Med; 2018 Oct; 11(10):e002087. PubMed ID: 30354297
[TBL] [Abstract][Full Text] [Related]
19. A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension.
Higasa K; Ogawa A; Terao C; Shimizu M; Kosugi S; Yamada R; Date H; Matsubara H; Matsuda F
BMC Pulm Med; 2017 Apr; 17(1):57. PubMed ID: 28388887
[TBL] [Abstract][Full Text] [Related]
20. Ion channels as convergence points in the pathology of pulmonary arterial hypertension.
Jouen-Tachoire TRH; Tucker SJ; Tammaro P
Biochem Soc Trans; 2021 Aug; 49(4):1855-1865. PubMed ID: 34346486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
